<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37516868</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>Longitudinal positron emission tomography and postmortem analysis reveals widespread neuroinflammation in SARS-CoV-2 infected rhesus macaques.</ArticleTitle><Pagination><StartPage>179</StartPage><MedlinePgn>179</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">179</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-023-02857-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease 2019 (COVID-19) patients initially develop respiratory symptoms, but they may also suffer from neurological symptoms. People with long-lasting effects after acute infections with severe respiratory syndrome coronavirus 2 (SARS-CoV-2), i.e., post-COVID syndrome or long COVID, may experience a variety of neurological manifestations. Although we do not fully understand how SARS-CoV-2 affects the brain, neuroinflammation likely plays a role.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To investigate neuroinflammatory processes longitudinally after SARS-CoV-2 infection, four experimentally SARS-CoV-2 infected rhesus macaques were monitored for 7 weeks with 18-kDa translocator protein (TSPO) positron emission tomography (PET) using [<sup>18</sup>F]DPA714, together with computed tomography (CT). The baseline scan was compared to weekly PET-CTs obtained post-infection (pi). Brain tissue was collected following euthanasia (50&#xa0;days pi) to correlate the PET signal with TSPO expression, and glial and endothelial cell markers. Expression of these markers was compared to brain tissue from uninfected animals of comparable age, allowing the examination of the contribution of these cells to the neuroinflammatory response following SARS-CoV-2 infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">TSPO PET revealed an increased tracer uptake throughout the brain of all infected animals already from the first scan obtained post-infection (day 2), which increased to approximately twofold until day 30 pi. Postmortem immunohistochemical analysis of the hippocampus and pons showed TSPO expression in cells expressing ionized calcium-binding adaptor molecule 1 (IBA1), glial fibrillary acidic protein (GFAP), and collagen IV. In the hippocampus of SARS-CoV-2 infected animals the TSPO<sup>+</sup> area and number of TSPO<sup>+</sup> cells were significantly increased compared to control animals. This increase was not cell type specific, since both the number of IBA1<sup>+</sup>TSPO<sup>+</sup> and GFAP<sup>+</sup>TSPO<sup>+</sup> cells was increased, as well as the TSPO<sup>+</sup> area within collagen IV<sup>+</sup> blood vessels.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study manifests [<sup>18</sup>F]DPA714 as a powerful radiotracer to visualize SARS-CoV-2 induced neuroinflammation. The increased uptake of [<sup>18</sup>F]DPA714 over time implies an active neuroinflammatory response following SARS-CoV-2 infection. This inflammatory signal coincides with an increased number of TSPO expressing cells, including glial and endothelial cells, suggesting neuroinflammation and vascular dysregulation. These results demonstrate the long-term neuroinflammatory response following a mild SARS-CoV-2 infection, which potentially precedes long-lasting neurological symptoms.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nieuwland</LastName><ForeName>Juliana M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurobiology and Aging, Biomedical Primate Research Centre (BPRC), Lange Kleiweg 161, 2288GJ, Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nutma</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurobiology and Aging, Biomedical Primate Research Centre (BPRC), Lange Kleiweg 161, 2288GJ, Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philippens</LastName><ForeName>Ingrid H C H M</ForeName><Initials>IHCHM</Initials><AffiliationInfo><Affiliation>Department of Neurobiology and Aging, Biomedical Primate Research Centre (BPRC), Lange Kleiweg 161, 2288GJ, Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;sz&#xf6;rm&#xe9;nyi</LastName><ForeName>Kinga P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remarque</LastName><ForeName>Edmond J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakker</LastName><ForeName>Jaco</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijer</LastName><ForeName>Lisette</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woerdman</LastName><ForeName>Noor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagrouch</LastName><ForeName>Zahra C</ForeName><Initials>ZC</Initials><AffiliationInfo><Affiliation>Department of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verstrepen</LastName><ForeName>Babs E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Department of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langermans</LastName><ForeName>Jan A M</ForeName><Initials>JAM</Initials><AffiliationInfo><Affiliation>Department of Animal Sciences, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Population Health Sciences, Unit Animals in Science and Society, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verschoor</LastName><ForeName>Ernst J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Windhorst</LastName><ForeName>Albert D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Tracer Center Amsterdam (TCA), Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bontrop</LastName><ForeName>Ronald E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Comparative Genetics and Refinement, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>Helga E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Stammes</LastName><ForeName>Marieke A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Radiology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Middeldorp</LastName><ForeName>Jinte</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurobiology and Aging, Biomedical Primate Research Centre (BPRC), Lange Kleiweg 161, 2288GJ, Rijswijk, The Netherlands. middeldorp@bprc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024141">Collagen Type IV</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499229">TSPO protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018079">Receptors, GABA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024141" MajorTopicYN="N">Collagen Type IV</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018079" MajorTopicYN="N">Receptors, GABA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Macaques</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Non-human primates</Keyword><Keyword MajorTopicYN="N">PET&#x2013;CT</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">TSPO</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>23</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37516868</ArticleId><ArticleId IdType="pmc">PMC10387202</ArticleId><ArticleId IdType="doi">10.1186/s12974-023-02857-z</ArticleId><ArticleId IdType="pii">10.1186/s12974-023-02857-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2&#x2014;the story so far. Nat Rev Neurol. 2021;17(2):65&#x2013;66. doi: 10.1038/s41582-020-00453-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00453-w</ArticleId><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen LT, Mukerji SS, Mejia NI. Post-acute neurological consequences of COVID-19: an unequal burden. Nat Med. 2022;28(1):20&#x2013;23. doi: 10.1038/s41591-021-01647-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01647-5</ArticleId><ArticleId IdType="pubmed">35039657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19&#x2014;a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4(5):e2112131. doi: 10.1001/jamanetworkopen.2021.12131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Sanchez CM, Diaz-Maroto I, Fernandez-Diaz E, Sanchez-Larsen A, Layos-Romero A, Garcia-Garcia J, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060&#x2013;e1070. doi: 10.1212/WNL.0000000000009937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021;11(1):13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser D, Golla SS, Verfaillie C, Coomans EM, Rikken RM, de GEMv, et al. Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET. medRxiv. 2022.</Citation></Reference><Reference><Citation>Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1(7):e290&#x2013;e299. doi: 10.1016/S2666-5247(20)30144-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30144-0</ArticleId><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Salie H, Tanevski J, Killmer S, Lago MS, Schlaak AE, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54(7):1594&#x2013;610e11. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595(7868):565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilarte TR. TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward. Pharmacol Ther. 2019;194:44&#x2013;58. doi: 10.1016/j.pharmthera.2018.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.09.003</ArticleId><ArticleId IdType="pmc">PMC6348013</ArticleId><ArticleId IdType="pubmed">30189290</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilarte TR, Rodichkin AN, McGlothan JL, Acanda De La Rocha AM, Azzam DJ. Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization. Pharmacol Ther. 2022;234:108048. doi: 10.1016/j.pharmthera.2021.108048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.108048</ArticleId><ArticleId IdType="pmc">PMC9107500</ArticleId><ArticleId IdType="pubmed">34848203</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlicot N, Vercouillie J, Ribeiro MJ, Tauber C, Venel Y, Baulieu JL, et al. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Nucl Med Biol. 2012;39(4):570&#x2013;578. doi: 10.1016/j.nucmedbio.2011.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2011.10.012</ArticleId><ArticleId IdType="pubmed">22172392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Haider A, Chen J, Xiao Z, Gobbi L, Honer M, et al. The repertoire of small-molecule PET probes for neuroinflammation imaging: challenges and opportunities beyond TSPO. J Med Chem. 2021;64(24):17656&#x2013;17689. doi: 10.1021/acs.jmedchem.1c01571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.1c01571</ArticleId><ArticleId IdType="pmc">PMC9094091</ArticleId><ArticleId IdType="pubmed">34905377</ArticleId></ArticleIdList></Reference><Reference><Citation>Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, et al. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients. J Cereb Blood Flow Metab. 2015;35(5):766&#x2013;772. doi: 10.1038/jcbfm.2014.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.261</ArticleId><ArticleId IdType="pmc">PMC4420859</ArticleId><ArticleId IdType="pubmed">25649991</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouilly D, Saint-Aubert L, Ribeiro MJ, Salabert AS, Tauber C, Peran P, et al. Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: an update. Eur J Neurosci. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35083791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagens MHJ, Golla SV, Wijburg MT, Yaqub M, Heijtel D, Steenwijk MD, et al. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [(18)F]DPA714 PET. J Neuroinflammation. 2018;15(1):314. doi: 10.1186/s12974-018-1352-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1352-9</ArticleId><ArticleId IdType="pmc">PMC6234549</ArticleId><ArticleId IdType="pubmed">30424780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutma E, Ceyzeriat K, Amor S, Tsartsalis S, Millet P, Owen DR, et al. Cellular sources of TSPO expression in healthy and diseased brain. Eur J Nucl Med Mol Imaging. 2021;49(1):146&#x2013;163. doi: 10.1007/s00259-020-05166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05166-2</ArticleId><ArticleId IdType="pmc">PMC8712293</ArticleId><ArticleId IdType="pubmed">33433698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutma E, Stephenson JA, Gorter RP, de Bruin J, Boucherie DM, Donat CK, et al. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain. 2019;142(11):3440&#x2013;3455. doi: 10.1093/brain/awz287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz287</ArticleId><ArticleId IdType="pmc">PMC6821167</ArticleId><ArticleId IdType="pubmed">31578541</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui Y, Marks JD, Das S, Hyman BT, Serrano-Pozo A. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains. Brain Pathol. 2020;30(1):151&#x2013;164. doi: 10.1111/bpa.12763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12763</ArticleId><ArticleId IdType="pmc">PMC6904423</ArticleId><ArticleId IdType="pubmed">31276244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutma E, Fancy N, Weinert M, Marzin MC, Tsartsalis S, Muirhead RCJ, et al. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases. bioRxiv. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10462763</ArticleId><ArticleId IdType="pubmed">37640701</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, et al. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Glia. 2021;69(10):2447&#x2013;2458. doi: 10.1002/glia.24052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24052</ArticleId><ArticleId IdType="pmc">PMC8453709</ArticleId><ArticleId IdType="pubmed">34145928</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung AL, Vanderheiden A, Nordvig AS, Sissoko CA, Canoll P, Mariani MB, et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1&#x2013;6. doi: 10.1007/s00401-020-02166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185(14):2452&#x2013;68e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalahmah O, Thakur KT, Nordvig AS, Prust ML, Roth W, Lignelli A, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun. 2020;8(1):147. doi: 10.1186/s40478-020-01024-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01024-2</ArticleId><ArticleId IdType="pmc">PMC7447601</ArticleId><ArticleId IdType="pubmed">32847628</ArticleId></ArticleIdList></Reference><Reference><Citation>Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267377</ArticleId><ArticleId IdType="pubmed">32333487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan D, Du T, Hong W, Chen L, Que H, Lu S, et al. Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther. 2021;6(1):406. doi: 10.1038/s41392-021-00818-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00818-7</ArticleId><ArticleId IdType="pmc">PMC8609271</ArticleId><ArticleId IdType="pubmed">34815399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiss CJ, Compton S, Veenhuis RT. Animal models of COVID-19. I. Comparative virology and disease pathogenesis. ILAR J. 2021;62(1&#x2013;2):35&#x2013;47. doi: 10.1093/ilar/ilab007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ilar/ilab007</ArticleId><ArticleId IdType="pmc">PMC8083356</ArticleId><ArticleId IdType="pubmed">33836527</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippens I, Boszormenyi KP, Wubben JAM, Fagrouch ZC, van Driel N, Mayenburg AQ, et al. Brain inflammation and intracellular alpha-synuclein aggregates in macaques after SARS-CoV-2 infection. Viruses. 2022;14(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9025893</ArticleId><ArticleId IdType="pubmed">35458506</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, Ning B, Huang Z, Monjure CJ, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. 2022;13(1):1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer L, Boszormenyi KP, Bakker J, Koopman G, Mooij P, Verel D, et al. Novel application of [(18)F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta) Nucl Med Biol. 2022;112&#x2013;113:1&#x2013;8. doi: 10.1016/j.nucmedbio.2022.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2022.05.002</ArticleId><ArticleId IdType="pmc">PMC9148436</ArticleId><ArticleId IdType="pubmed">35660200</ArticleId></ArticleIdList></Reference><Reference><Citation>Boszormenyi KP, Stammes MA, Fagrouch ZC, Kiemenyi-Kayere G, Niphuis H, Mortier D, et al. The post-acute phase of SARS-CoV-2 infection in two macaque species is associated with signs of ongoing virus replication and pathology in pulmonary and extrapulmonary tissues. Viruses. 2021;13(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8402919</ArticleId><ArticleId IdType="pubmed">34452537</ArticleId></ArticleIdList></Reference><Reference><Citation>Stammes MA, Lee JH, Meijer L, Naninck T, Doyle-Meyers LA, White AG, et al. Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates. Trends Mol Med. 2022;28(2):123&#x2013;142. doi: 10.1016/j.molmed.2021.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.12.001</ArticleId><ArticleId IdType="pmc">PMC8648672</ArticleId><ArticleId IdType="pubmed">34955425</ArticleId></ArticleIdList></Reference><Reference><Citation>Stammes MA, Bakker J, Vervenne RAW, Zijlmans DGM, van Geest L, Vierboom MPM, et al. Recommendations for standardizing thorax PET&#x2013;CT in non-human primates by recent experience from macaque studies animals. 2021;11(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7830664</ArticleId><ArticleId IdType="pubmed">33467761</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung B, Taylor PA, Seidlitz J, Sponheim C, Perkins P, Ungerleider LG, et al. A comprehensive macaque fMRI pipeline and hierarchical atlas. Neuroimage. 2021;235:117997. doi: 10.1016/j.neuroimage.2021.117997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2021.117997</ArticleId><ArticleId IdType="pmc">PMC9272767</ArticleId><ArticleId IdType="pubmed">33789138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartig R, Glen D, Jung B, Logothetis NK, Paxinos G, Garza-Villarreal EA, et al. The subcortical atlas of the rhesus macaque (SARM) for neuroimaging. Neuroimage. 2021;235:117996. doi: 10.1016/j.neuroimage.2021.117996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2021.117996</ArticleId><ArticleId IdType="pubmed">33794360</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao L, Yang Y, Yu W, Zhao Y, Long H, Gao J, et al. The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys. Signal Transduct Target Ther. 2021;6(1):169. doi: 10.1038/s41392-021-00591-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00591-7</ArticleId><ArticleId IdType="pmc">PMC8065334</ArticleId><ArticleId IdType="pubmed">33895780</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, et al. Neuropathological features of Covid-19. N Engl J Med. 2020;383(10):989&#x2013;992. doi: 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijl JP, Nienhuis PH, Kwee TC, Glaudemans A, Slart R, Gormsen LC. Limitations and pitfalls of FDG-PET/CT in infection and inflammation. Semin Nucl Med. 2021;51(6):633&#x2013;645. doi: 10.1053/j.semnuclmed.2021.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semnuclmed.2021.06.008</ArticleId><ArticleId IdType="pubmed">34246448</ArticleId></ArticleIdList></Reference><Reference><Citation>Nylund M, Sucksdorff M, Matilainen M, Polvinen E, Tuisku J, Airas L. Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET. Brain Commun. 2022;4(1):fcab301. doi: 10.1093/braincomms/fcab301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab301</ArticleId><ArticleId IdType="pmc">PMC8727984</ArticleId><ArticleId IdType="pubmed">34993478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavenex P, Banta Lavenex P, Amaral DG. Postnatal development of the primate hippocampal formation. Dev Neurosci. 2007;29(1&#x2013;2):179&#x2013;192. doi: 10.1159/000096222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000096222</ArticleId><ArticleId IdType="pubmed">17148960</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser EI, Moser MB, McNaughton BL. Spatial representation in the hippocampal formation: a history. Nat Neurosci. 2017;20(11):1448&#x2013;1464. doi: 10.1038/nn.4653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4653</ArticleId><ArticleId IdType="pubmed">29073644</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachevalier J. Nonhuman primate models of hippocampal development and dysfunction. Proc Natl Acad Sci USA. 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6936345</ArticleId><ArticleId IdType="pubmed">31871159</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeles Fernandez-Gil M, Palacios-Bote R, Leo-Barahona M, Mora-Encinas JP. Anatomy of the brainstem: a gaze into the stem of life. Semin Ultrasound CT MR. 2010;31(3):196&#x2013;219. doi: 10.1053/j.sult.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sult.2010.03.006</ArticleId><ArticleId IdType="pubmed">20483389</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen DR, Narayan N, Wells L, Healy L, Smyth E, Rabiner EA, et al. Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans. J Cereb Blood Flow Metab. 2017;37(8):2679&#x2013;2690. doi: 10.1177/0271678X17710182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X17710182</ArticleId><ArticleId IdType="pmc">PMC5536262</ArticleId><ArticleId IdType="pubmed">28530125</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 2020;14:198. doi: 10.3389/fncel.2020.00198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00198</ArticleId><ArticleId IdType="pmc">PMC7424058</ArticleId><ArticleId IdType="pubmed">32848611</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews MG, Mukhtar T, Eze UC, Simoneau CR, Ross J, Parikshak N, et al. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc Natl Acad Sci USA. 2022;119(30):e2122236119. doi: 10.1073/pnas.2122236119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2122236119</ArticleId><ArticleId IdType="pmc">PMC9335272</ArticleId><ArticleId IdType="pubmed">35858406</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckman D, Bonillas A, Diniz GB, Ott S, Roh JW, Elizaldi SR, et al. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep. 2022;41(5):111573. doi: 10.1016/j.celrep.2022.111573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111573</ArticleId><ArticleId IdType="pmc">PMC9554328</ArticleId><ArticleId IdType="pubmed">36288725</ArticleId></ArticleIdList></Reference><Reference><Citation>Colodner KJ, Montana RA, Anthony DC, Folkerth RD, De Girolami U, Feany MB. Proliferative potential of human astrocytes. J Neuropathol Exp Neurol. 2005;64(2):163&#x2013;169. doi: 10.1093/jnen/64.2.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/64.2.163</ArticleId><ArticleId IdType="pubmed">15751231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan JS, Gao K, Chai RC, Jia XH, Luo DP, Ge G, et al. Astrocytes in migration. Neurochem Res. 2017;42(1):272&#x2013;282. doi: 10.1007/s11064-016-2089-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-016-2089-4</ArticleId><ArticleId IdType="pubmed">27837318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright P, Veronese M, Mazibuko N, Turkheimer FE, Rabiner EA, Ballard CG, et al. Patterns of mitochondrial TSPO binding in cerebral small vessel disease: an in vivo PET study with neuropathological comparison. Front Neurol. 2020;11:541377. doi: 10.3389/fneur.2020.541377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.541377</ArticleId><ArticleId IdType="pmc">PMC7596201</ArticleId><ArticleId IdType="pubmed">33178101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosu GC, Mateescu VO, Simionescu A, Istrate-Ofiteru AM, Curca GC, Pirici I, et al. Subtle vascular and astrocytic changes in the brain of coronavirus disease 2019 (COVID-19) patients. Eur J Neurol. 2022;29(12):3676&#x2013;3692. doi: 10.1111/ene.15545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15545</ArticleId><ArticleId IdType="pmc">PMC9539405</ArticleId><ArticleId IdType="pubmed">36056566</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell'Isola A, Kiadaliri A, Turkiewicz A, Runhaar J, et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13(1):7363. doi: 10.1038/s41467-022-35240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo D, Falasca L, Marchioni L, Tammaro A, Adebanjo GAR, Ippolito G, et al. Neuropathology and inflammatory cell characterization in 10 autoptic COVID-19 brains. Cells. 2021;10(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8469459</ArticleId><ArticleId IdType="pubmed">34571912</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroujeni ME, Simani L, Bluyssen HAR, Samadikhah HR, ZamanluiBenisi S, Hassani S, et al. Inflammatory response leads to neuronal death in human post-mortem cerebral cortex in patients with COVID-19. ACS Chem Neurosci. 2021;12(12):2143&#x2013;2150. doi: 10.1021/acschemneuro.1c00111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00111</ArticleId><ArticleId IdType="pubmed">34100287</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingaropoli MA, Iannetta M, Piermatteo L, Pasculli P, Latronico T, Mazzuti L, et al. Neuro-axonal damage and alteration of blood&#x2013;brain barrier integrity in COVID-19 patients. Cells. 2022;11(16).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9406414</ArticleId><ArticleId IdType="pubmed">36010557</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>